EGFR and lung carcinoma: Non‐small‐cell lung cancer (NSCLC) is the most common type of lung cancer, and many NSCLC patients are diagnosed at advanced stages, two‐thirds of which harbor epidermal growth factor receptor (EGFR) mutations [1].